12 Of Japan’s 13 Drug Makers Expect Higher Profits This Year

All but one of Japan's 13 pharmaceutical companies are expected to see increased profits this year, according to national survey of drug makers. Only Astellas Pharma is expected to end the year lower than the year before. The survey of companies indicates they have been relatively immune to recent economic downturns. Another factor is seen in the government's schedule for reviewing drug prices, now not scheduled before April of next year. Drug makers Hisamitsu Pharmaceutical and Tsumura are expected to post double-digit profit increases this year. (Click here for more - a subscription may be required